Delivery Order SPE2DB24D2109-SPE2DB24FHVXJ

Award Date 7/30/24
Potential Completion Date 8/20/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,553.31, is for the delivery of 4565242920 INGREZZA 40 MG CAPSULE 30S. The contract is a firm fixed-price delivery order with an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 60 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $7,828.66 and a period of performance through August 21, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen, through its Corporate Office division, has been awarded this delivery order as part of its extensive...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,027.70, is for the delivery of INGREZZA 80 MG CAPSULE 30S, a medication used to treat a neurological condition. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,676.12, is for the supply of 4568039004 INGREZZA 40 MG CAPSULE 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 4,565,215,434 units of the pharmaceutical product INGREZZA 40 MG CAPSULE 30S. The contract has a ceiling value of $10,659.93 and is a firm-fixed-price delivery order, with an ultimate completion date of August 9, 2024. The contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $3,553.31, is for the supply of INGREZZA 40 MG CAPSULE 30S, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of August 20, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INGREZZA 40 MG CAPSULE 30S, a pharmaceutical product, with a ceiling value of $3,676.12 and a completion date of July 23, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a $4,027.70 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through July 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of INGREZZA 40 MG CAPSULE 30S. The contract has a ceiling value of $3,553.31 and a period of performance through October 2, 2024. It is a firm-fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of essential medical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 60 mg INGREZZA capsules. The order, valued at $4,755.32, has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is a prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary...
  • SPE2DB24D2109
    Indefinite Delivery Contract
  • SPE2DB24D2109-SPE2DB24FHVXJ
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $3,553.31, is for the supply of 4,565,296,598 units of the pharmaceutical product INGREZZA 40 MG CAPSULE 30S. The delivery order has an ultimate completion date of August 20, 2024. No set-aside was used for this contract, and it is structured as a firm fixed-price delivery order. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal government, including military treatment facilities and veterans' hospitals. The company holds several Indefinite Delivery Contracts (IDCs) with agencies like the DLA and the Department of Justice, valued up to $999,999,999 and $750,000 respectively, to provide a wide range of medical commodities to support federal healthcare programs.

Generated 10/29/24, 9:04 AM